Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Robeauté logo — Therapeutic microrobots, smaller than a grain of rice

Robeauté

Therapeutic microrobots, smaller than a grain of rice

Founded 2017 France France 40 employees Series A Total: $5.94M

General Information

Company Name Robeauté
Founded Year 2017
Location France France
Employees 40
Funding Stage Series A
Business Model B2B, D2C, B2D
Revenue Model Product Sales, Service Fee, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Robeauté. To contact Robeauté, visit robeaute.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Robeauté compare?

A PDF of Robeauté and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Robeauté soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Robeauté

Robeauté, founded in 2017 and headquartered in France, is at the forefront of revolutionizing brain healthcare through its pioneering work with therapeutic microrobots. These robots are described by the company as being smaller than a grain of rice and are designed to diagnose, treat, and monitor brain activity with unmatched precision and adaptability.

Positioned at the intersection of microrobotics, engineering, and medicine, Robeauté thrives on a culture that welcomes both conventional and unconventional thinkers, fostering a multidisciplinary and multicultural team. This approach underlines their commitment to innovation and collaboration in a rapidly evolving technological landscape.

The company recently secured a €2.50M Series A investment on 01 February 2025, with funding led by the European Innovation Council. This injection of capital positions Robeauté to further expand its capabilities and attract top-tier talent, ensuring sustained momentum in its mission to reshape brain healthcare.

Business keywords: therapeutic microrobots, brain diagnostics, brain treatment, brain monitoring, microrobotics, biomedical engineering, interdisciplinary team, innovation in medicine, precision healthcare, remote health monitoring, minimally invasive technology, medical device innovation, neuroscience

Services & Products

Development and provision of therapeutic microrobots
Design and engineering of modular medical devices
Adaptation for diverse clinical applications such as tissue sampling, therapy delivery, and electrode implantation

Target Customers

Neurosurgeons Medical institutions and hospitals Healthcare researchers Medical device distributors Research facilities focusing on brain-related conditions

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €2.50M 1
European Innovation Council
European Innovation Council
01 Feb 2025
Support Program Undisclosed 1
MedTech Innovator
MedTech Innovator
01 May 2024
Seed $3.40M 2
Apex Ventures Urania Ventures
Apex Ventures, Urania Ventures
01 Jan 2022
Support Program €40.00K 1
EIT Health
01 Jun 2020
Spinout Undisclosed 2
University Ventures
University Ventures, SATT LUTECH
01 Apr 2016

Latest News

View All
Paris-based Newfund closes €60 million HEKA, a specialist fund for BrainTech — Eu-startups
Paris-based Newfund closes €60 million HEKA, a specialist fund for BrainTech
Eu-startups Apr 14, 2026
Robeauté is turning microrobotics into a surgical platform for the brain — Tech
Robeauté is turning microrobotics into a surgical platform for the brain
Tech Jan 02, 2026

Robeauté Alternatives & Competitors

View All Alternatives
Robeauté vs
Melzi Corporation
Melzi Corporation United States

To create cost-effective technology that improves patient outcomes while reducing hospital expenses.

Series A
16 employees
Manufacturing
Robeauté vs
Neuralink
Neuralink United States

Neuralink is developing ultra-high bandwidth brain-machine interfaces to connect humans and computer...

Series E
674 employees
Biotechnology, Robotics
Robeauté vs
MYndspan
MYndspan United Kingdom

Extending healthy cognitive lifespans.

9 employees
Analytics, Health Care
View all alternatives

FAQ About Robeauté

Therapeutic microrobots, smaller than a grain of rice
Robeauté was founded in 2017.
Robeauté is headquartered in France.
Robeauté has a B2B, D2C and B2D business model. Its revenue comes from Product Sales, Service Fee and Usage Based.
Robeauté has approximately 40 employees.
Robeauté has completed 5 funding rounds, raising a total of $5.94M. The latest funding stage is Series A.
Robeauté offers: Development and provision of therapeutic microrobots, Design and engineering of modular medical devices, Adaptation for diverse clinical applications such as tissue sampling, therapy delivery, and electrode implantation.
Top alternatives and competitors to Robeauté include Melzi Corporation, Neuralink, MYndspan, HealthTech Connex Inc., CorTec. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Robeauté and Melzi Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Robeauté, https://bouncewatch.com/company/robeaute, updated 13 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout